Overview Fundamentals API Earnings EOD API Sample Code Pricing

THERANEXUS EO -25 (3VG F) stock market data APIs

€0.468 0(0%) as of October 29, 2024
Price chart is built with Anychart

Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.

THERANEXUS EO -25 Financial Data Overview

0.468
0.468
-
0.468
0.468
0.434-1.22
4 175 K
7 814 K
2 265 K
2.383
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '3VG',
Type: 'Common Stock',
Name: 'THERANEXUS EO -25',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'FR0013286259',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

THERANEXUS EO -25 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 265 K
  • EBITDA -3 812 487
  • Earnings Per Share -0.17
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get THERANEXUS EO -25 Earnings via APIs

  • Latest Release 2024-10-23
  • EPS/Forecast NaN

Get THERANEXUS EO -25 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com